FDAFDA · Food and drugs·Recall number D-0655-2020
Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
Published January 22, 2020 · Recall initiated: December 17, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Motto International Corp
- Distributor
- TX
- Lot
- All lots remaining within expiry.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.